Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP437803.RAli89Gb6-oQGQiltwKDyhe4l9T0rxqIVCzP8hihH1ig0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP437803.RAli89Gb6-oQGQiltwKDyhe4l9T0rxqIVCzP8hihH1ig0130_assertion type Assertion NP437803.RAli89Gb6-oQGQiltwKDyhe4l9T0rxqIVCzP8hihH1ig0130_head.
- NP437803.RAli89Gb6-oQGQiltwKDyhe4l9T0rxqIVCzP8hihH1ig0130_assertion description "[Overall, these data show that promoter methylation-mediated loss of ITIH5 expression is associated with unfavourable outcome in breast cancer patients, and thus ITIH5 could be used as a prognostic marker, although this marker is not multivariate independent due to its close association with ER expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP437803.RAli89Gb6-oQGQiltwKDyhe4l9T0rxqIVCzP8hihH1ig0130_provenance.
- NP437803.RAli89Gb6-oQGQiltwKDyhe4l9T0rxqIVCzP8hihH1ig0130_assertion evidence source_evidence_literature NP437803.RAli89Gb6-oQGQiltwKDyhe4l9T0rxqIVCzP8hihH1ig0130_provenance.
- NP437803.RAli89Gb6-oQGQiltwKDyhe4l9T0rxqIVCzP8hihH1ig0130_assertion SIO_000772 17653090 NP437803.RAli89Gb6-oQGQiltwKDyhe4l9T0rxqIVCzP8hihH1ig0130_provenance.
- NP437803.RAli89Gb6-oQGQiltwKDyhe4l9T0rxqIVCzP8hihH1ig0130_assertion wasDerivedFrom befree-20140225 NP437803.RAli89Gb6-oQGQiltwKDyhe4l9T0rxqIVCzP8hihH1ig0130_provenance.
- NP437803.RAli89Gb6-oQGQiltwKDyhe4l9T0rxqIVCzP8hihH1ig0130_assertion wasGeneratedBy ECO_0000203 NP437803.RAli89Gb6-oQGQiltwKDyhe4l9T0rxqIVCzP8hihH1ig0130_provenance.